Yamanouchi Pharmaceutical Co., Ltd. , Keio University Discover Target Molecule For Anti-obesity And Antidiabetic Drug 
10/19/2005 5:13:07 PM

Tokyo (JCNN) - Yamanouchi Pharmaceutical (TSE: 4503) announced that it has discovered a promising target molecule for the development of anti-obesity and antidiabetic drug, in collaboration with Keio University. Through mice experiments, the joint research group has confirmed that an Angiopoietin-related growth factor (AGF) has properties to improve obesity and diabetic symptoms. AGF is a protein secreted by liver.